187 related articles for article (PubMed ID: 25119690)
1. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
Shah M; Dowdy D; Joloba M; Ssengooba W; Manabe YC; Ellner J; Dorman SE
AIDS; 2013 Nov; 27(18):2883-92. PubMed ID: 25119690
[TBL] [Abstract][Full Text] [Related]
2. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
[TBL] [Abstract][Full Text] [Related]
5. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
6. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
Vassall A; van Kampen S; Sohn H; Michael JS; John KR; den Boon S; Davis JL; Whitelaw A; Nicol MP; Gler MT; Khaliqov A; Zamudio C; Perkins MD; Boehme CC; Cobelens F
PLoS Med; 2011 Nov; 8(11):e1001120. PubMed ID: 22087078
[TBL] [Abstract][Full Text] [Related]
8. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
9. Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
Fekadu G; Wang Y; You JHS
PLoS One; 2023; 18(7):e0288605. PubMed ID: 37450476
[TBL] [Abstract][Full Text] [Related]
10. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
[TBL] [Abstract][Full Text] [Related]
11. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
[TBL] [Abstract][Full Text] [Related]
12. Microscopic observation drug-susceptibility assay vs. Xpert
Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
14. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
[TBL] [Abstract][Full Text] [Related]
17. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
20. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
